Editorial: What Can be Learned from National and International Vaccine Adverse Event Reporting Systems During the COVID-19 Pandemic?

Related articles

01 Jan 2023 : Editorial

Editorial: Current Status of Two Adjuvanted Malaria Vaccines and the World Health Organization (WHO) Strategy to Eradicate Malaria by 2030

Dinah V. Parums,

DOI: 10.12659/MSM.939357

29 Apr 2023 : Database Analysis

Clinical Course of 53 Previously Vaccinated Patients Admitted to the National Hospital in Warsaw, Poland with COVID-19 Between November 2021 and March 2022

Artur Zaczyński, Michał Hampel, [...] Paweł Piątkiewicz, Jacek Nasiłowski, Sławomir Butkiewicz, Urszula Religioni, Agnieszka Barańska, Maria Malm , Agnieszka Neumann-Podczaska , Regis Vaillancourt, Piotr Merks - Show fewer authors

DOI: 10.12659/MSM.939841

01 Jul 2023 : Editorial

Editorial: Post-Acute Sequelae of SARS-CoV-2 Infection (PASC). Updated Terminology for the Long-Term Effects of COVID-19

Dinah V. Parums,

DOI: 10.12659/MSM.941595

01 Nov 2023 : Editorial

Editorial: Factors Driving New Variants of SARS-CoV-2, Immune Escape, and Resistance to Antiviral Treatments as the End of the COVID-19 Pandemic is Declared

Dinah V. Parums,

DOI: 10.12659/MSM.942960

01 Dec 2023 : Editorial

Editorial: Outbreaks of Post-Pandemic Childhood Pneumonia and the Re-Emergence of Endemic Respiratory Infections

Dinah V. Parums,

DOI: 10.12659/MSM.943312

01 Dec 2022 : Editorial

Editorial: The World Health Organization (WHO) Fungal Priority Pathogens List in Response to Emerging Fungal Pathogens During the COVID-19 Pandemic

Dinah V. Parums,

DOI: 10.12659/MSM.939088

01 Feb 2022 : Editorial

Editorial: The 2022 World Health Organization (WHO) Priority Recommendations and Response to the Omicron Variant (B.1.1.529) of SARS-CoV-2

Dinah V. Parums,

DOI: 10.12659/MSM.936199

01 Mar 2022 : Editorial

Editorial: First Approval of the Protein-Based Adjuvanted Nuvaxovid (NVX-CoV2373) Novavax Vaccine for SARS-CoV-2 Could Increase Vaccine Uptake and Provide Immune Protection from Viral Variants

Dinah V. Parums,

DOI: 10.12659/MSM.936523

21 Mar 2022 : Review article

A Review of Recent Studies on the Effects of SARS-CoV-2 Infection and SARS-CoV-2 Vaccines on Male Reproductive Health

Leila Adamyan, Vladimir Elagin, [...] Valeriy Vechorko, Assia Stepanian, Anton Dashko, Dmitriy Doroshenko, Yana Aznaurova, Maxim Sorokin, Andrew Garazha, Anton Buzdin - Show fewer authors

DOI: 10.12659/MSM.935879

01 May 2022 : Editorial

Editorial: Cardiovascular Complications at One Year After SARS-CoV-2 Infection are Independent of Underlying Cardiovascular Risk Factors or Severity of COVID-19

Dinah V. Parums,

DOI: 10.12659/MSM.937048

01 Jul 2022 : Editorial

Editorial: World Health Organization (WHO) Variants of Concern Lineages Under Monitoring (VOC-LUM) in Response to the Global Spread of Lineages and Sublineages of Omicron, or B.1.1.529, SARS-CoV-2

Dinah V. Parums,

DOI: 10.12659/MSM.937676

01 Aug 2022 : Editorial

Editorial: Long-Term Effects of Symptomatic and Asymptomatic SARS-CoV-2 Infection in Children and the Changing Pathogenesis of Common Childhood Viruses Driven by the COVID-19 Pandemic

Dinah V. Parums,

DOI: 10.12659/MSM.937927

01 Oct 2022 : Editorial

Editorial: Rebound COVID-19 and Cessation of Antiviral Treatment for SARS-CoV-2 with Paxlovid and Molnupiravir

Dinah V. Parums,

DOI: 10.12659/MSM.938532

12 Oct 2022 : Review article

Effects of Physiotherapy on Rehabilitation and Quality of Life in Patients Hospitalized for COVID-19: A Review of Findings from Key Studies Published 2020-2022

Samire Beqaj, Amra Mačak Hadžiomerović, [...] Arzija Pašalić, Amila Jaganjac - Show fewer authors

DOI: 10.12659/MSM.938141

01 Jan 2022 : Editorial

Editorial: Current Status of Oral Antiviral Drug Treatments for SARS-CoV-2 Infection in Non-Hospitalized Patients

Dinah V. Parums,

DOI: 10.12659/MSM.935952

01 Dec 2021 : Editorial

Editorial: SARS-CoV-2 Vaccine Responses and Breakthrough COVID-19

Dinah V. Parums,

DOI: 10.12659/MSM.935624

04 Oct 2021 : Editorial

Editorial: A Decline in Influenza During the COVID-19 Pandemic and the Emergence of Potential Epidemic and Pandemic Influenza Viruses

Dinah V. Parums,

DOI: 10.12659/MSM.934949

11 Oct 2021 : Editorial

Editorial: Multisystem Inflammatory Syndrome in Adults (MIS-A) and the Spectrum of COVID-19

Dinah V. Parums,

DOI: 10.12659/MSM.935005

18 Oct 2021 : Editorial

Editorial: Global Initiatives Support the Use and Regulation of Digital Health Technology During the COVID-19 Pandemic

Dinah V. Parums,

DOI: 10.12659/MSM.935123